155 related articles for article (PubMed ID: 33662888)
1. Opsoclonus After COVID-19 in an Infant.
Heald DL; Devine IM; Smith RL; Holsopple SAT; Arasmith JL; Arnold RW
Pediatr Neurol; 2021 Apr; 117():34. PubMed ID: 33662888
[No Abstract] [Full Text] [Related]
2. Pediatric Opsoclonus-Myoclonus-Ataxia Syndrome Associated With Anti-N-methyl-D-aspartate Receptor Encephalitis.
Player B; Harmelink M; Bordini B; Weisgerber M; Girolami M; Croix M
Pediatr Neurol; 2015 Nov; 53(5):456-8. PubMed ID: 26341674
[TBL] [Abstract][Full Text] [Related]
3. Acute cerebellar ataxia and myoclonus with or without opsoclonus: a para-infectious syndrome associated with COVID-19.
Foucard C; San-Galli A; Tarrano C; Chaumont H; Lannuzel A; Roze E
Eur J Neurol; 2021 Oct; 28(10):3533-3536. PubMed ID: 33492711
[TBL] [Abstract][Full Text] [Related]
4. Immunotherapy responsive SARS-CoV-2 infection exacerbating opsoclonus myoclonus syndrome.
Wiegand SE; Mitchell WG; Santoro JD
Mult Scler Relat Disord; 2021 May; 50():102855. PubMed ID: 33677410
[TBL] [Abstract][Full Text] [Related]
5. Post-COVID-19 opsoclonus-myoclonus syndrome and encephalopathy associated with leucine-rich glioma-inactivated 1 (LGI-1) antibodies.
Smyth D; Kyaw KM; Legister A; MacFarlane G; Sankar UU; Patel M; Clough C; Kulendran A; Mulroy E
J Neurol Sci; 2021 Nov; 430():119982. PubMed ID: 34543933
[No Abstract] [Full Text] [Related]
6. Opsoclonus-myoclonus syndrome in anti-N-methyl-D-aspartate receptor encephalitis.
Kurian M; Lalive PH; Dalmau JO; Horvath J
Arch Neurol; 2010 Jan; 67(1):118-21. PubMed ID: 20065141
[TBL] [Abstract][Full Text] [Related]
7. Opsoclonus-Myoclonus-Ataxia Syndrome (OMAS) Associated with SARS-CoV-2 Infection: Post-Infectious Neurological Complication with Benign Prognosis.
Urrea-Mendoza E; Okafor K; Ravindran S; Absher J; Chaubal V; Revilla FJ
Tremor Other Hyperkinet Mov (N Y); 2021 Feb; 11():7. PubMed ID: 33614199
[TBL] [Abstract][Full Text] [Related]
8. Opsoclonus myoclonus ataxia syndrome in severe acute respiratory syndrome coronavirus-2.
Fernandes J; Puhlmann P
J Neurovirol; 2021 Jun; 27(3):501-503. PubMed ID: 33788141
[TBL] [Abstract][Full Text] [Related]
9. Opsoclonus-myoclonus syndrome, a post-infectious neurologic complication of COVID-19: case series and review of literature.
Emamikhah M; Babadi M; Mehrabani M; Jalili M; Pouranian M; Daraie P; Mohaghegh F; Aghavali S; Zaribafian M; Rohani M
J Neurovirol; 2021 Feb; 27(1):26-34. PubMed ID: 33492608
[TBL] [Abstract][Full Text] [Related]
10. N-methyl-D-aspartate receptor autoimmune encephalitis presenting with opsoclonus-myoclonus: treatment response to plasmapheresis.
Smith JH; Dhamija R; Moseley BD; Sandroni P; Lucchinetti CF; Lennon VA; Kantarci OH
Arch Neurol; 2011 Aug; 68(8):1069-72. PubMed ID: 21825245
[TBL] [Abstract][Full Text] [Related]
11. Opsoclonus-Myoclonus-Ataxia Syndrome Related to the Novel Coronavirus (COVID-19).
Sanguinetti SY; Ramdhani RA
J Neuroophthalmol; 2021 Sep; 41(3):e288-e289. PubMed ID: 32925477
[TBL] [Abstract][Full Text] [Related]
12. Opsoclonus myoclonus syndrome secondary to Epstein-Barr virus infection.
Sheth RD; Horwitz SJ; Aronoff S; Gingold M; Bodensteiner JB
J Child Neurol; 1995 Jul; 10(4):297-9. PubMed ID: 7594265
[TBL] [Abstract][Full Text] [Related]
13. Opsoclonus and neuroblastoma.
Davidson M; Tolentino Y; Sapir S
N Engl J Med; 1968 Oct; 279(17):948. PubMed ID: 20617606
[No Abstract] [Full Text] [Related]
14. 78-year-old woman with opsoclonus myoclonus ataxia syndrome secondary to COVID-19.
Saha B; Saha S; Chong WH
BMJ Case Rep; 2021 May; 14(5):. PubMed ID: 34049895
[No Abstract] [Full Text] [Related]
15. Infection-Associated Opsoclonus: A Retrospective Case Record Analysis and Review of Literature.
Saini L; Dhawan SR; Madaan P; Suthar R; Saini AG; Sahu JK; Sankhyan N
J Child Neurol; 2020 Jun; 35(7):480-484. PubMed ID: 32216501
[TBL] [Abstract][Full Text] [Related]
16. Opsoclonus myoclonus syndrome in a patient with Japanese encephalitis: a case report.
Sountharalingam S; Herath HMMTB; Wijegunasinghe D; Senanayke S
J Med Case Rep; 2017 Oct; 11(1):294. PubMed ID: 29058581
[TBL] [Abstract][Full Text] [Related]
17. The opsoclonus–myoclonus syndrome.
Sahu JK; Prasad K
Pract Neurol; 2011 Jun; 11(3):160-6. PubMed ID: 21551110
[TBL] [Abstract][Full Text] [Related]
18. Two COVID-19-related video-accompanied cases of severe ataxia-myoclonus syndrome.
Przytuła F; Błądek S; Sławek J
Neurol Neurochir Pol; 2021; 55(3):310-313. PubMed ID: 34096013
[TBL] [Abstract][Full Text] [Related]
19. Opsoclonus-myoclonus-ataxia syndrome in children.
Bhatia P; Heim J; Cornejo P; Kane L; Santiago J; Kruer MC
J Neurol; 2022 Feb; 269(2):750-757. PubMed ID: 33779841
[TBL] [Abstract][Full Text] [Related]
20. A novel treatment-responsive encephalitis with frequent opsoclonus and teratoma.
Armangue T; Titulaer MJ; Sabater L; Pardo-Moreno J; Gresa-Arribas N; Barbero-Bordallo N; Kelley GR; Kyung-Ha N; Takeda A; Nagao T; Takahashi Y; Lizcano A; Carr AS; Graus F; Dalmau J
Ann Neurol; 2014 Mar; 75(3):435-41. PubMed ID: 23613036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
